Literature DB >> 18799154

Abnormal endothelium-dependent microvascular dilator reactivity in pregnancies complicated by normotensive intrauterine growth restriction.

Corine M Koopmans1, Judith Blaauw, Maria G van Pampus, Gerhard Rakhorst, Jan G Aarnoudse.   

Abstract

OBJECTIVE: Normotensive intrauterine growth restriction and preeclampsia share a similar placenta pathophysiology, whereas maternal clinical manifestations differ. Clinical symptoms of preeclampsia are partly attributed to vascular endothelial dysfunction, but it is unclear whether this phenomenon plays a role in intrauterine growth restriction. Therefore, we investigated microvascular endothelial function in women with intrauterine growth restriction. STUDY
DESIGN: Laser Doppler fluxmetry was used combined with iontophoresis of acetylcholine and sodium nitroprusside, namely, endothelium-dependent and endothelium-independent vasodilators. We studied 12 women with intrauterine growth restriction and 16 controls in the third trimester of pregnancy. All women had prepregnancy body mass indexes < 26.
RESULTS: Acetylcholine-mediated vasodilatation was significantly increased in women with intrauterine growth restriction compared with controls (743% +/- 120% vs 390% +/- 67%, P = .01); sodium nitroprusside-mediated vasodilatation was not different (360% +/- 55% vs 363% +/- 65%, P > .99).
CONCLUSION: Nonobese women with normotensive intrauterine growth restriction show abnormal endothelium-dependent microvascular vasodilatation, suggesting endothelial dysfunction as in preeclampsia. Obviously, for the clinical manifestation of preeclampsia additional factors are required, and a role of metabolic syndrome and obesity has been suggested.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799154     DOI: 10.1016/j.ajog.2008.07.022

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Flow-mediated vasodilation is not attenuated in hypertensive pregnancies despite biochemical signs of inflammation.

Authors:  Heli Saarelainen; Henna Kärkkäinen; Pirjo Valtonen; Kari Punnonen; Tomi Laitinen; Nonna Heiskanen; Tiina Lyyra-Laitinen; Esko Vanninen; Seppo Heinonen
Journal:  ISRN Obstet Gynecol       Date:  2012-01-17

2.  New conception for the development of hypertension in preeclampsia.

Authors:  Qinqin Gao; Jiaqi Tang; Na Li; Xiuwen Zhou; Xiaolin Zhu; Weisheng Li; Bailin Liu; Xueqin Feng; Jianying Tao; Bing Han; Hong Zhang; Miao Sun; Zhice Xu
Journal:  Oncotarget       Date:  2016-11-29

3.  Differences in expression of Peroxisome Proliferator-activated Receptor-γ in early-onset preeclampsia and late-onset preeclampsia.

Authors:  W Permadi; K I Mantilidewi; A F Khairani; U A Lantika; A R Ronosulistyo; H Bayuaji
Journal:  BMC Res Notes       Date:  2020-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.